Sun et al. reported that circMYBL2 expression to be about 5-fold higher in AML patient samples with FLT3-ITD mutations (FLT3-ITD+) compared with those without FLT3-ITD mutation (FLT3-ITD-). The gene discussed is FLT3; the disease is acute myeloid leukemia.